COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders

The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources.

The Guidance covers

• 1 Communicating with patients and minimising risk
• 2 Patients not known to have COVID-19
• 3 Patients known or suspected to have COVID-19
• 4 Treatment considerations
• 5 Drug monitoring
• 6 Modifications to usual care
• 7 Healthcare workers